COSMOS HEALTH INC.

NASDAQ: COSM (Cosmos Health Inc.)

Kemas kini terakhir: 21 Jan, 3:05PM

0.520

0.02 (4.99%)

Penutupan Terdahulu 0.495
Buka 0.500
Jumlah Dagangan 2,047,335
Purata Dagangan (3B) 738,790
Modal Pasaran 19,419,932
Harga / Jualan (P/S) 0.230
Harga / Buku (P/B) 0.800
Julat 52 Minggu
0.280 (-46%) — 1.32 (153%)
Tarikh Pendapatan 16 Apr 2025
Margin Keuntungan -28.26%
Margin Operasi (TTM) -6.08%
EPS Cair (TTM) -1.09
Pertumbuhan Hasil Suku Tahunan (YOY) -6.00%
Jumlah Hutang/Ekuiti (D/E MRQ) 49.51%
Nisbah Semasa (MRQ) 1.05
Aliran Tunai Operasi (OCF TTM) -4.49 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -1.94 M
Pulangan Atas Aset (ROA TTM) -14.90%
Pulangan Atas Ekuiti (ROE TTM) -50.03%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Distribution (US) Menaik Bercampur
Medical Distribution (Global) Menaik Bercampur
Stok Cosmos Health Inc. - -

AISkor Stockmoo

1.0
Konsensus Penganalisis 2.0
Aktiviti Orang Dalam 2.5
Volatiliti Harga -2.0
Purata Bergerak Teknikal 1.5
Osilator Teknikal 1.0
Purata 1.00

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
COSM 19 M - - 0.800
QIPT 157 M - - 1.58
EDAP 153 M - - 5.68
HSIC 10 B - 24.78 2.64
ZYXI 9 M - - 34.84
AHG 879 M - - 3.94

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Sektor Healthcare
Industri Medical Distribution
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 31.08%
% Dimiliki oleh Institusi 9.46%

Tiada data dalam julat masa ini.

Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
SIOKAS GRIGORIOS 0.497 - 443,646 219,876
Jumlah Keseluruhan Kuantiti Bersih 443,646
Jumlah Keseluruhan Nilai Bersih ($) 219,876
Purata Pembelian Keseluruhan ($) 0.497
Purata Jualan Keseluruhan ($) -
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
SIOKAS GRIGORIOS Pegawai 23 Jan 2026 Beli (+) 90,325 0.498 44,982
SIOKAS GRIGORIOS Pegawai 20 Jan 2026 Beli (+) 353,321 0.495 174,894
Tarikh Jenis Butiran
20 Jan 2026 Pengumuman Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
20 Jan 2026 Pengumuman Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
14 Jan 2026 Pengumuman Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
14 Jan 2026 Pengumuman Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
05 Jan 2026 Pengumuman Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
05 Jan 2026 Pengumuman Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
24 Dec 2025 Pengumuman Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
19 Dec 2025 Pengumuman Cosmos Health is Forcing the Market to Reframe the Conversation
03 Dec 2025 Pengumuman Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
03 Dec 2025 Pengumuman Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
02 Dec 2025 Pengumuman Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
02 Dec 2025 Pengumuman Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
17 Nov 2025 Pengumuman Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
17 Nov 2025 Pengumuman Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda